CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Dialysis patient service revenues	$ 12,260,375	$ 11,574,941	$ 11,176,464
Other revenues	555,175	565,206	433,430
Total revenues	12,815,550	12,140,147	11,609,894
Operating expenses:
Patient care costs	8,598,521	8,319,717	8,209,553
General and administrative	1,538,341	1,473,984	1,355,197
Depreciation and amortization	723,860	745,443	732,602
Equity investment income, net	(26,189)	(27,864)	(26,520)
Goodwill impairment charges	0	26,083	0
Gain on changes in ownership interests	(109,466)	0	0
Total operating expenses	10,725,067	10,537,363	10,270,832
Operating income	2,090,483	1,602,784	1,339,062
Debt expense	(470,469)	(398,551)	(357,019)
Debt prepayment, extinguishment and modification costs	(19,813)	(7,962)	0
Other loss, net	(69,808)	(19,177)	(15,765)
Income from continuing operations before income taxes	1,530,393	1,177,094	966,278
Income tax expense	279,656	220,116	198,087
Net income from continuing operations	1,250,737	956,978	768,191
Net income from discontinued operations, net of tax	0	0	13,452
Net income	1,250,737	956,978	781,643
Less: Net income attributable to noncontrolling interests	(314,395)	(265,443)	(221,243)
Net income attributable to DaVita Inc.	$ 936,342	$ 691,535	$ 560,400
Earnings per share attributable to DaVita Inc.:
Basic net income from continuing operations	$ 11.02	$ 7.62	$ 5.88
Basic net income	11.02	7.62	6.03
Diluted net income from continuing operations	10.73	7.42	5.71
Diluted net income	$ 10.73	$ 7.42	$ 5.85
Weighted average shares for earnings per share:
Basic shares (in shares)	84,991,000	90,790,000	92,992,000
Diluted shares (in shares)	87,274,000	93,182,000	95,834,000
Amounts attributable to DaVita Inc.:
Net income from continuing operations	$ 936,342	$ 691,535	$ 546,948
Net income from discontinued operations	0	0	13,452
Net (loss) income attributable to DaVita Inc.	$ 936,342	$ 691,535	$ 560,400